Cargando…
Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes’ Hearts
Background: Hypertrophic cardiomyopathy (HCM), hypertensive heart disease (HHD) and athletes’ heart share an increased prevalence of atrial fibrillation. Atrial cardiomyopathy in these patients may have different characteristics and help to distinguish these conditions. Methods: In this single-cente...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910879/ https://www.ncbi.nlm.nih.gov/pubmed/35268407 http://dx.doi.org/10.3390/jcm11051316 |
_version_ | 1784666605197721600 |
---|---|
author | Servatius, Helge Raab, Simon Asatryan, Babken Haeberlin, Andreas Branca, Mattia de Marchi, Stefano Brugger, Nicolas Nozica, Nikolas Goulouti, Eleni Elchinova, Elena Lam, Anna Seiler, Jens Noti, Fabian Madaffari, Antonio Tanner, Hildegard Baldinger, Samuel H. Reichlin, Tobias Wilhelm, Matthias Roten, Laurent |
author_facet | Servatius, Helge Raab, Simon Asatryan, Babken Haeberlin, Andreas Branca, Mattia de Marchi, Stefano Brugger, Nicolas Nozica, Nikolas Goulouti, Eleni Elchinova, Elena Lam, Anna Seiler, Jens Noti, Fabian Madaffari, Antonio Tanner, Hildegard Baldinger, Samuel H. Reichlin, Tobias Wilhelm, Matthias Roten, Laurent |
author_sort | Servatius, Helge |
collection | PubMed |
description | Background: Hypertrophic cardiomyopathy (HCM), hypertensive heart disease (HHD) and athletes’ heart share an increased prevalence of atrial fibrillation. Atrial cardiomyopathy in these patients may have different characteristics and help to distinguish these conditions. Methods: In this single-center study, we prospectively collected and analyzed electrocardiographic (12-lead ECG, signal-averaged ECG (SAECG), 24 h Holter ECG) and echocardiographic data in patients with HCM and HHD and in endurance athletes. Patients with atrial fibrillation were excluded. Results: We compared data of 27 patients with HCM (70% males, mean age 50 ± 14 years), 324 patients with HHD (52% males, mean age 75 ± 5.5 years), and 215 endurance athletes (72% males, mean age 42 ± 7.5 years). HCM patients had significantly longer filtered P-wave duration (153 ± 26 ms) and PR interval (191 ± 48 ms) compared to HHD patients (144 ± 16 ms, p = 0.012 and 178 ± 31, p = 0.034, respectively) and athletes (134 ± 14 ms, p = 0.001 and 165 ± 26 ms, both p < 0.001, respectively). HCM patients had a mean of 4.9 ± 16 premature atrial complexes per hour. Premature atrial complexes per hour were significantly more frequent in HHD patients (27 ± 86, p < 0.001), but not in athletes (2.7 ± 23, p = 0.639). Left atrial volume index (LAVI) was 43 ± 14 mL/m(2) in HCM patients and significantly larger than age- and sex-corrected LAVI in HHD patients 30 ± 10 mL/m(2); p < 0.001) and athletes (31 ± 9.5 mL/m(2); p < 0.001). A borderline interventricular septum thickness ≥13 mm and ≤15 mm was found in 114 (35%) HHD patients, 12 (6%) athletes and 3 (11%) HCM patients. Conclusions: Structural and electrical atrial remodeling is more advanced in HCM patients compared to HHD patients and athletes. |
format | Online Article Text |
id | pubmed-8910879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89108792022-03-11 Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes’ Hearts Servatius, Helge Raab, Simon Asatryan, Babken Haeberlin, Andreas Branca, Mattia de Marchi, Stefano Brugger, Nicolas Nozica, Nikolas Goulouti, Eleni Elchinova, Elena Lam, Anna Seiler, Jens Noti, Fabian Madaffari, Antonio Tanner, Hildegard Baldinger, Samuel H. Reichlin, Tobias Wilhelm, Matthias Roten, Laurent J Clin Med Article Background: Hypertrophic cardiomyopathy (HCM), hypertensive heart disease (HHD) and athletes’ heart share an increased prevalence of atrial fibrillation. Atrial cardiomyopathy in these patients may have different characteristics and help to distinguish these conditions. Methods: In this single-center study, we prospectively collected and analyzed electrocardiographic (12-lead ECG, signal-averaged ECG (SAECG), 24 h Holter ECG) and echocardiographic data in patients with HCM and HHD and in endurance athletes. Patients with atrial fibrillation were excluded. Results: We compared data of 27 patients with HCM (70% males, mean age 50 ± 14 years), 324 patients with HHD (52% males, mean age 75 ± 5.5 years), and 215 endurance athletes (72% males, mean age 42 ± 7.5 years). HCM patients had significantly longer filtered P-wave duration (153 ± 26 ms) and PR interval (191 ± 48 ms) compared to HHD patients (144 ± 16 ms, p = 0.012 and 178 ± 31, p = 0.034, respectively) and athletes (134 ± 14 ms, p = 0.001 and 165 ± 26 ms, both p < 0.001, respectively). HCM patients had a mean of 4.9 ± 16 premature atrial complexes per hour. Premature atrial complexes per hour were significantly more frequent in HHD patients (27 ± 86, p < 0.001), but not in athletes (2.7 ± 23, p = 0.639). Left atrial volume index (LAVI) was 43 ± 14 mL/m(2) in HCM patients and significantly larger than age- and sex-corrected LAVI in HHD patients 30 ± 10 mL/m(2); p < 0.001) and athletes (31 ± 9.5 mL/m(2); p < 0.001). A borderline interventricular septum thickness ≥13 mm and ≤15 mm was found in 114 (35%) HHD patients, 12 (6%) athletes and 3 (11%) HCM patients. Conclusions: Structural and electrical atrial remodeling is more advanced in HCM patients compared to HHD patients and athletes. MDPI 2022-02-27 /pmc/articles/PMC8910879/ /pubmed/35268407 http://dx.doi.org/10.3390/jcm11051316 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Servatius, Helge Raab, Simon Asatryan, Babken Haeberlin, Andreas Branca, Mattia de Marchi, Stefano Brugger, Nicolas Nozica, Nikolas Goulouti, Eleni Elchinova, Elena Lam, Anna Seiler, Jens Noti, Fabian Madaffari, Antonio Tanner, Hildegard Baldinger, Samuel H. Reichlin, Tobias Wilhelm, Matthias Roten, Laurent Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes’ Hearts |
title | Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes’ Hearts |
title_full | Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes’ Hearts |
title_fullStr | Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes’ Hearts |
title_full_unstemmed | Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes’ Hearts |
title_short | Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes’ Hearts |
title_sort | differences in atrial remodeling in hypertrophic cardiomyopathy compared to hypertensive heart disease and athletes’ hearts |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910879/ https://www.ncbi.nlm.nih.gov/pubmed/35268407 http://dx.doi.org/10.3390/jcm11051316 |
work_keys_str_mv | AT servatiushelge differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT raabsimon differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT asatryanbabken differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT haeberlinandreas differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT brancamattia differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT demarchistefano differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT bruggernicolas differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT nozicanikolas differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT gouloutieleni differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT elchinovaelena differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT lamanna differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT seilerjens differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT notifabian differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT madaffariantonio differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT tannerhildegard differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT baldingersamuelh differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT reichlintobias differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT wilhelmmatthias differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts AT rotenlaurent differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts |